Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by BJERKHOLT ERIC, Chief Financial Officer. Insider active across 5 companies, notably CERUS CORP. Aggregated, 43 reports have been recorded. Split: 10 buys · 11 sells. Total volume traded: €1.1m. Activity tracked since 1 June 2022. The latest transaction was disclosed on 6 July 2026 (Cession). Regulator: SEC (Form 4). All data is free.
10,000 shares@ US$1.71513.5% of flowCommon StockSEC:0001209191-23-047110:0
Ideal exit: 17 May 2024 (T+270)
25 of 43 declarations
About BJERKHOLT ERIC
Eric Bjerkholt is the Chief Financial Officer and Director at Cerus Corp and Chinook Therapeutics, Inc. In these roles, he is responsible for the financial management of the companies, including financial planning and regulatory compliance. Bjerkholt plays a key role in developing financial strategies and optimizing economic performance. His expertise in finance is crucial for supporting the growth of the companies.